Recurrent first trimester pregnancy loss: Revised definitions and novel causes

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 16, Issue 6, 2009, Pages 446-450

  Allison, Jana L ^a   Schust, Danny J ^a  

^a University of Missouri   (United States)

Author keywords

Hypercoagulability; Immunology; Miscarriage; Placenta; Recurrent pregnancy loss; Thrombophilia

Indexed keywords

CARDIOLIPIN ANTIBODY; GLUCOSE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROGESTERONE; PROLACTIN; REACTIVE OXYGEN METABOLITE; THYROTROPIN; VASCULOTROPIN; VIPER VENOM;

ACTIVATED PROTEIN C RESISTANCE; ANEUPLOIDY; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; FIRST TRIMESTER PREGNANCY; GENETIC POLYMORPHISM; GENETIC SCREENING; GESTATIONAL AGE; HUMAN; INCIDENCE; INTRACYTOPLASMIC SPERM INJECTION; KARYOTYPE; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; PARTIAL THROMBOPLASTIN TIME; PLACENTA FUNCTION; PREGNANCY DISORDER; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; RECURRENT DISEASE; REVIEW; THROMBOPHILIA; THROMBOSIS; UTERUS DISEASE;

ABORTION, HABITUAL; ADULT; FEMALE; HUMANS; MALE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; YOUNG ADULT;

EID: 70350752355     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283327fc5     Document Type: Review

References (37)

1. Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 2009. [Epub ahead of print]
2. Definitions of infertility and recurrent pregnancy loss. Fertil Steril 2008; 90: S60.
3. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
4. Vora S, Shetty S, Ghosh K. Thrombophilic dimension of recurrent fetal loss in Indian patients. Blood Coagul Fibrinolysis 2008; 19:581-584.
5. Alijotas-Reig J, Casellas-Caro M, Ferrer-Oliveras R, et al. Are antibeta-glycoprotein- I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/ anticardiolipin seronegative women? Am J Reprod Immunol 2008; 60:229-237.
6. Alijotas-Reig J, Ferrer-Oliveras R, Rodrigo-Anoro MJ, et al. Antibeta(2)-glycoprotein- I and antiphosphatidylserine antibodies in women with spontaneous pregnancy loss. Fertil Steril 2009. [Epub ahead of print]
7. Tebo AE, Jaskowski TD, Hill HR, et al. Clinical relevance of multiple antibody specificity testing in antiphospholipid syndrome and recurrent pregnancy loss. Clin Exp Immunol 2008; 154:332-338.
8. Kovalevsky G, Gracia CR, Berlin JA, et al. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: A metaanalysis. Arch Intern Med 2004; 164:558-563.
9. Nelen WL, Blom HJ, Steegers EA, et al. Hyperhomocysteinemia and recurrent early pregnancy loss: A meta-analysis. Fertil Steril 2000; 74:1196-1199.
10. Rey E, Kahn SR, David M, et al. Thrombophilic disorders and fetal loss: A metaanalysis. Lancet 2003; 361:901-908.
11. Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: A systematic review. Br J Haematol 2006; 132:171-196.
12. Dossenbach-Glaninger A, van Trotsenburg M, Schneider B, et al. ACE I/D polymorphism and recurrent first trimester pregnancy loss: Interaction with SERPINE1 4G/5G and F13 Val34Leu polymorphisms. Br J Haematol 2008; 141:269-271.
13. Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach M, et al. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: Impaired fibrinolysis and early pregnancy loss. Clin Chem 2003; 49:1081-1086.
14. Sood R. Thrombophilia and fetal loss: lessons from gene targeting in mice. Thromb Res 2009; 123 (Suppl 2):S79-S84.
15. Redecha P, van Rooijen N, Torry D, et al. Pravastatin prevents miscarriages in mice: Role of tissue factor in placental and fetal injury. Blood 2009; 113: 4101-4109.
16. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 2001; 21:1712-1719.
17. Wei JL, Cui HM, Ma CY. Simvastatin inhibits tissue factor and plasminogen activator inhibitor-1 secretion by peripheral blood mononuclear cells in patients with primary nephrotic syndrome. Eur J Med Res 2007; 12:216-221.
18. Bolor H, Mori T, Nishiyama S, et al. Mutations of the SYCP3 gene in women with recurrent pregnancy loss. Am J Hum Genet 2009; 84:14-20.
19. Miyamoto T, Hasuike S, Yogev L, et al. Azoospermia in patients heterozygous for a mutation in SYCP3. Lancet 2003; 362:1714-1719.
20. Qu X, Yang M, Zhang W, et al. Osteopontin expression in human decidua is associated with decidual natural killer cells recruitment and regulated by progesterone. In Vivo 2008; 22:55-61.
21. Quenby S, Nik H, Innes B, et al. Uterine natural killer cells and angiogenesis in recurrent reproductive failure. Hum Reprod 2009; 24:45-54.
22. Faridi RM, Das V, Tripthi G, et al. Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages. Hum Reprod 2009; 24:1758-1764.
23. Vargas RG, Bompeixe EP, Franca PP, et al. Activating killer cell immunoglobulin- like receptor genes' association with recurrent miscarriage. Am J Reprod Immunol 2009; 62:34-43.
24. Hiby SE, Regan L, Lo W, et al. Association of maternal killer-cell immunoglobulin- like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod 2008; 23:972-976.
25. Trowsdale J, Moffett A. NK receptor interactions with MHC class I molecules in pregnancy. Semin Immunol 2008; 20:317-320.
26. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380:435-439.
27. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380:439-442.
28. Papazoglou D, Galazios G, Papatheodorou K, et al. Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss. Fertil Steril 2005; 83:959-963.
29. Lee HH, Hong SH, Shin SJ, et al. Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortion. Fertil Steril 2009 [Epub ahead of print].
30. Coulam CB, Jeyendran RS. Vascular endothelial growth factor gene polymorphisms and recurrent pregnancy loss. Am J Reprod Immunol 2008; 59:301-305.
31. Galazios G, Papazoglou D, Tsikouras P, et al. Vascular endothelial growth factor gene polymorphisms and pregnancy. J Matern Fetal Neonatal Med 2009; 22:371-378.
32. Gil-Villa AM, Cardona-Maya W, Agarwal A, et al. Role of male factor in early recurrent embryo loss: Do antioxidants have any effect? Fertil Steril 2009; 92:565-571.
33. Dewan S, Puscheck EE, Coulam CB, et al. Y-chromosome microdeletions and recurrent pregnancy loss. Fertil Steril 2006; 85:441-445.
34. Kaare M, Painter JN, Ulander VM, et al. Sex chromosome characteristics and recurrent miscarriage. Fertil Steril 2008; 90:2328-2333.
35. Govindaiah V, Naushad SM, Prabhakara K, et al. Association of parental hyperhomocysteinemia and C677T Methylene tetrahydrofolate reductase (MTHFR) polymorphism with recurrent pregnancy loss. Clin Biochem 2009; 42:380-386.
36. Gil-Villa AM, Cardona-Maya W, Agarwal A, et al. Assessment of sperm factors possibly involved in early recurrent pregnancy loss. Fertil Steril 2009. [Epub ahead of print]
37. Greco E, Romano S, Iacobelli M, et al. ICSI in cases of sperm DNA damage: beneficial effect of oral antioxidant treatment. Hum Reprod 2005; 20:2590-2594.